Science & Enterprise subscription

Follow us on Twitter

  • Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences li… https://t.co/WGboSsrf7U
    about 16 hours ago
  • New post on Science and Enterprise: Gene Therapy Company Exploring DNA Circuit Technology https://t.co/2YUM4DVZRK #Science #Business
    about 16 hours ago
  • A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects again… https://t.co/3JtSqD1Sa2
    about 20 hours ago
  • New post on Science and Enterprise: Vaccine Stops Lyme Bacteria in Preclinical Test https://t.co/7H0Lc90nRe #Science #Business
    about 20 hours ago
  • Stop the panic porn ... Coronavirus Variants Don’t Have to Be Scary. Still, Mask Up. https://t.co/d6aDu2Ucj6
    about 23 hours ago

Please share Science & Enterprise

Infographic – Countries Making Covid-19 Vaccines

Chart: Covid-19 vaccine sites

Click on image for full-size view. (Statista)

9 Jan. 2021. The U.S. and India are set to produce two-thirds of the world’s Covid-19 vaccine doses by the end of this year, presenting worldwide distribution challenges. These data are drawn from a report on the German radio network Deutsche Welle and published yesterday by business data company Statista.

The Deutsche Welle story is based on statistics compiled by the life sciences data company Airfinity that calculated Covid-19 vaccine production capacities of various countries. The findings show the U.S. can produce 4.7 billion doses of Covid-19 vaccines beginning in 2020 and continuing through 2021, accounting for 41 percent of the 11.5 billion doses expected to be produced.

India, a leading pharma manufacturing country in normal times, anticipates producing another 3.1 billion doses, or 27 percent of the total. China, the U.K., Germany, and South Korea are expected to produce the remaining 3.7 billion vaccine doses.

As we’ve discussed a number of times in Science & Enterprise, manufacturing is one thing and distribution is quite another. Much of the world’s population will depend on the Covax facility, an international effort backed by World Health Organization, European Union, and non-government organizations to provide worldwide equitable access to Covid-19 vaccines. Up to now, the U.S. has declined to take part in Covax, but recent legislation and the incoming Biden administration will likely change that.

More from Science & Enterprise:

*     *     *

1 comment to Infographic – Countries Making Covid-19 Vaccines